BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., reported preliminary May revenue of approximately $22,344 for its recently acquired subsidiary Ancient Extracts, representing a 76% increase month-over-month from April's $12,670. The company also received a purchase order on June 2 for approximately $58,823 in retail product value, with a wholesale price of $29,411.
The acquisition of VerdaGenix LLC d/b/a Ancient Extracts USA closed in mid-May, meaning the reported May revenue reflects only a partial month under UNLOCKD ownership. Management views these early results as validation of the acquisition strategy. "We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing," stated CEO John P. Gorst.
Ancient Extracts offers a portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha, shilajit, and wellness-focused goods under the philosophy "Ancient Remedies for Modern Life." The company believes the brand benefits from growing consumer interest in functional mushrooms, adaptogens, and evidence-informed health approaches.
Dr. Jordan P. Balencic, Chairman and Chief Science Officer, noted, "When we evaluated Ancient Extracts, we believed the business possessed attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple growth pathways." He added, "Our objective is to grow revenue, expand distribution, strengthen our portfolio, and execute with discipline."
Separately, the UNLOCKD Technologies division has initiated preliminary planning for future consumer health technology opportunities, including point-of-care testing concepts. These initiatives remain in early stages, and the company expects to pursue dedicated financing for such projects.
For more information, visit www.unlockdinc.com and follow @BFCHco on X for updates.
